KK-2269
- Generic Name
- KK-2269
A Study of KK2269 in Adult Participants With Solid Tumors
Phase 1
Recruiting
- Conditions
- Metastatic Solid TumorEsophageal AdenocarcinomaAdvanced Solid TumorGastroesophageal Junction AdenocarcinomaNon Small Cell Lung CancerGastric Adenocarcinoma
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 71
- Registration Number
- NCT06266299
- Locations
- 🇺🇸
City Of Hope, Duarte, California, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇯🇵Aichi Cancer Center, Nagoya city, Aichi, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath